● Recruiting

Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis

Condition: Endometriosis · Sponsor: Alcea

PhasePhase 3

Planned participants290

Who can joinFemale, 18 Years to 45 Years

Healthy volunteersNo

About this study

Prospective open-label randomized parallel groups study to compare efficacy and safety of Indinol Forto® 200 mg capsules and Visanne 2 mg tablets in treatment of endometriosis. This is phase 3 study, based on hypothesis of non-inferiority.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (8)

Research Site	Kazan', Russia	Not Yet Recruiting
Research Site	Moscow, Russia	Not Yet Recruiting
Research Site	Rostov-on-Don, Russia	Not Yet Recruiting
Research Site	Ryazan, Russia	Recruiting
Research Site	Saint Petersburg, Russia	Not Yet Recruiting
Research Site	Smolensk, Russia	Recruiting
Research Site	Tver', Russia	Not Yet Recruiting
Research Site	Yaroslavl, Russia	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07164183